Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes-Reference-Cited by-同舟云学术

Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes

Published:2017-03 Issue: Volume:201 Page:240-251
ISSN:0378-1135
Container-title:Veterinary Microbiology
language:en
Short-container-title:Veterinary Microbiology

Author:

Chowdhury Mohammed Y.E.,Kim Tae-Hwan,Uddin Md Bashir,Kim Jae-Hoon,Hewawaduge C.Y.,Ferdowshi Zannatul,Sung Moon-Hee,Kim Chul-Joong,Lee Jong-Soo

Funder

Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea

Internal Research Fund of Animal Quarantine and Inspection Agency (QIA)

Chungnam National University

Publisher

Elsevier BV

Subject

General Veterinary,General Medicine,Microbiology

Reference49 articles.

1. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid);Akagi;Macromol. Biosci.,2005

2. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens;Bacon;Infect. Immun.,2000

3. Nanotechnology solutions for mucosal immunization;Chadwick;Adv. Drug Deliv. Rev.,2010

4. Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice;Chowdhury;PLoS One,2014

5. Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice;Chowdhury;Virol. J.,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan biopolymer and its composites: Processing, properties and applications- A comprehensive review;Hybrid Advances;2024-08

2. Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses;Frontiers in Immunology;2023-10-19

3. Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies;Vaccines;2022-12-01

4. Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy;Materials Today Advances;2022-08

5. Progress towards the Development of a Universal Influenza Vaccine;Viruses;2022-07-30